Florian Sennlaub
10Patents
1h-index
28Co-inventors
50Inventor score
Filing activity: Jun 18, 2008 → May 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9434766B2 | CCR2 antagonist peptides | Human Necessities | 2 | Active |
| US8435954B2 | Azapeptides as CD36 binding compounds | Physics | 1 | Active |
| US9115171B2 | Azapeptides as CD36 binding compounds | Physics | 1 | Active |
| US10519232B2 | Agents for use in the treatment of retinal inflammation | Chemistry; Metallurgy | 1 | Active |
| US9708370B2 | Azapeptides as CD36 binding compounds | Physics | 0 | Active |
| US11142548B2 | Agents that activate CD47 and their use in the treatment of inflammation | Human Necessities | 0 | Active |
| US11191807B2 | Lebecetin, a C-type lectin, as neovascularization inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8603964B2 | Methods for modulating angiogenesis via dystrophin Dp71 | Human Necessities | 0 | Active |
| US10253087B2 | CCR2 antagonist peptides | Human Necessities | 0 | Active |
| US11072661B2 | Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.